Breaking News Instant updates and real-time market news.

LTC

LTC Properties

$33.94 /

+0.61 (+1.83%)

08:44
05/05/20
05/05
08:44
05/05/20
08:44

LTC Properties upgraded to Overweight from Equalweight at Capital One

Capital One analyst Daniel Bernstein upgraded LTC Properties to Overweight from Equalweight with a $39 price target.

  • 27

    May

LTC LTC Properties
$33.94 /

+0.61 (+1.83%)

03/11/20 Mizuho
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho
02/26/20 Berenberg
LTC Properties upgraded to Buy from Hold at Berenberg
12/19/19 Mizuho
LTC Properties assumed with a Neutral at Mizuho
12/10/19 Wells Fargo
LTC Properties downgraded to Underperform from Market Perform at Wells Fargo

TODAY'S FREE FLY STORIES

Hot Stocks
Onex Partners, BPEA announce secondary offering of Clarivate » 08:14
06/04/20
06/04
08:14
06/04/20
08:14
ONEXF

Onex

$0.00 /

+ (+0.00%)

, CCC

Clarivate Analytics

$22.90 /

-0.46 (-1.97%)

Onex Corporation (ONEXF),…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONEXF Onex
$0.00 /

+ (+0.00%)

CCC Clarivate Analytics
$22.90 /

-0.46 (-1.97%)

ONEXF Onex
$0.00 /

+ (+0.00%)

05/19/20 Stifel
Onex price target raised to C$88.50 from C$85.80 at Stifel
05/19/20 CIBC
Onex price target lowered to C$81 from C$82 at CIBC
04/28/20 Canaccord
Onex price target raised to C$72 from C$68 at Canaccord
04/21/20 Scotiabank
Onex upgraded to Outperform from Sector Perform at Scotiabank
CCC Clarivate Analytics
$22.90 /

-0.46 (-1.97%)

05/06/20 Citi
Clarivate Analytics price target raised to $28 from $24 at Citi
04/09/20 Goldman Sachs
Clarivate Analytics upgraded to Buy from Neutral at Goldman Sachs
04/03/20 Citi
Clarivate reinstated with a Buy from Neutral at Citi (yesterday)
04/02/20 Citi
Clarivate Analytics upgraded to Buy from Neutral at Citi
CCC Clarivate Analytics
$22.90 /

-0.46 (-1.97%)

  • 04
    Jun
CCC Clarivate Analytics
$22.90 /

-0.46 (-1.97%)

Recommendations
Aaron's price target raised to $50 from $40 at SunTrust » 08:14
06/04/20
06/04
08:14
06/04/20
08:14
AAN

Aaron's

$39.71 /

+1.26 (+3.28%)

SunTrust analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAN Aaron's
$39.71 /

+1.26 (+3.28%)

AAN Aaron's
$39.71 /

+1.26 (+3.28%)

05/08/20 Stifel
Stifel would continue to be 'aggressive buyers' of Aaron's after earnings
05/08/20 Raymond James
Aaron's price target lowered to $50 from $60 at Raymond James
05/08/20 SunTrust
Aaron's price target raised to $40 from $25 at SunTrust
05/08/20 Stephens
Aaron's price target raised to $45 from $26 at Stephens
AAN Aaron's
$39.71 /

+1.26 (+3.28%)

AAN Aaron's
$39.71 /

+1.26 (+3.28%)

AAN Aaron's
$39.71 /

+1.26 (+3.28%)

Recommendations
Guidewire price target raised to $88 from $80 at Wells Fargo » 08:14
06/04/20
06/04
08:14
06/04/20
08:14
GWRE

Guidewire

$110.35 /

+3.635 (+3.41%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GWRE Guidewire
$110.35 /

+3.635 (+3.41%)

GWRE Guidewire
$110.35 /

+3.635 (+3.41%)

06:24 Today BTIG
Guidewire price target raised to $130 from $100 at BTIG
04/29/20 Baird
Guidewire downgraded to Neutral at Baird
04/29/20 Baird
Guidewire downgraded to Neutral from Outperform at Baird
04/17/20 Guggenheim
Guidewire downgraded to Neutral from Buy at Guggenheim
GWRE Guidewire
$110.35 /

+3.635 (+3.41%)

GWRE Guidewire
$110.35 /

+3.635 (+3.41%)

Hot Stocks
89bio appoints Lota Zoth to board of directors » 08:13
06/04/20
06/04
08:13
06/04/20
08:13
ETNB

89bio

$25.14 /

+1.49 (+6.30%)

89bio announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETNB 89bio
$25.14 /

+1.49 (+6.30%)

ETNB 89bio
$25.14 /

+1.49 (+6.30%)

12/09/19 Oppenheimer
89bio initiated with an Outperform at Oppenheimer
12/09/19 SVB Leerink
89bio initiated with an Outperform at SVB Leerink
12/09/19 RBC Capital
89bio initiated with an Outperform at RBC Capital
12/09/19 BofA/Merrill
89bio initiated with a Neutral at BofA/Merrill
ETNB 89bio
$25.14 /

+1.49 (+6.30%)

Recommendations
Federal Realty price target raised to $100 from $85 at Wells Fargo » 08:12
06/04/20
06/04
08:12
06/04/20
08:12
FRT

Federal Realty

$93.49 /

+5.18 (+5.87%)

Wells Fargo analyst Tammi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRT Federal Realty
$93.49 /

+5.18 (+5.87%)

FRT Federal Realty
$93.49 /

+5.18 (+5.87%)

04/22/20 Wells Fargo
Federal Realty price target lowered to $85 from $149 at Wells Fargo
04/22/20 JPMorgan
JPMorgan downgrades seven, upgrades one strip center REIT
04/22/20 JPMorgan
Federal Realty downgraded to Neutral from Overweight at JPMorgan
04/20/20 Evercore ISI
Federal Realty downgraded to Underperform from In Line at Evercore ISI
FRT Federal Realty
$93.49 /

+5.18 (+5.87%)

Conference/Events
Commodity Futures Trading Commission holds a teleconference » 08:12
06/04/20
06/04
08:12
06/04/20
08:12

The CFTC discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Alpine Immune Sciences presents new B cell disease program at EULAR E-Congress » 08:11
06/04/20
06/04
08:11
06/04/20
08:11
ALPN

Alpine Immune Sciences

$4.09 /

+0.1 (+2.51%)

Alpine Immune Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALPN Alpine Immune Sciences
$4.09 /

+0.1 (+2.51%)

ALPN Alpine Immune Sciences
$4.09 /

+0.1 (+2.51%)

04/27/20 Piper Sandler
Piper Sandler backs Overweight rating for Alpine after study design presented
11/13/19 Piper Jaffray
Alpine Immune Sciences price target lowered to $8 from $11 at Piper Jaffray
ALPN Alpine Immune Sciences
$4.09 /

+0.1 (+2.51%)

ALPN Alpine Immune Sciences
$4.09 /

+0.1 (+2.51%)

Hot Stocks
Moderna appoints David Meline as CFO » 08:11
06/04/20
06/04
08:11
06/04/20
08:11
MRNA

Moderna

$59.89 /

+0.005 (+0.01%)

Moderna (MRNA) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

Hot Stocks
Oxford Lane sees NAV $2.87-$2.97 as of May 31 » 08:11
06/04/20
06/04
08:11
06/04/20
08:11
OXLC

Oxford Lane

$4.81 /

+0.13 (+2.78%)

Oxford Lane Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OXLC Oxford Lane
$4.81 /

+0.13 (+2.78%)

OXLC Oxford Lane
$4.81 /

+0.13 (+2.78%)

OXLC Oxford Lane
$4.81 /

+0.13 (+2.78%)

Conference/Events
FDA PDUFA Date for Merck RECARBRIO is June 4, 2020  08:10
06/04/20
06/04
08:10
06/04/20
08:10
MRK

Merck

$82.07 /

+1.22 (+1.51%)

 
ShowHide Related Items >><<
MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

Recommendations
K12 price target raised to $32 from $30 at BMO Capital » 08:10
06/04/20
06/04
08:10
06/04/20
08:10
LRN

K12

$26.04 /

+0.09 (+0.35%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRN K12
$26.04 /

+0.09 (+0.35%)

LRN K12
$26.04 /

+0.09 (+0.35%)

01/28/20 Barrington
K12 price target lowered to $30 from $40 at Barrington
01/28/20 BMO Capital
K12 price target lowered to $23 from $27 at BMO Capital
08/13/19 William Blair
William Blair starts Chegg, K12 with Outperform ratings
08/12/19 William Blair
K12 initiated with an Outperform at William Blair
LRN K12
$26.04 /

+0.09 (+0.35%)

LRN K12
$26.04 /

+0.09 (+0.35%)

Recommendations
Autodesk price target raised to $250 from $240 at Wells Fargo » 08:10
06/04/20
06/04
08:10
06/04/20
08:10
ADSK

Autodesk

$226.18 /

+7.205 (+3.29%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

07:33 Today Credit Suisse
Autodesk price target raised to $240 from $225 at Credit Suisse
06:49 Today Mizuho
Autodesk price target raised to $250 from $225 at Mizuho
06:25 Today Barclays
Autodesk price target raised to $250 from $230 at Barclays
04:51 Today Stifel
Autodesk price target raised to $245 from $210 at Stifel
ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

Hot Stocks
CHF Solutions says CHKD launches ultrafiltration therapy using Aquadex SmartFlow » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
CHFS

CHF Solutions

$0.37 /

+0.0068 (+1.90%)

CHF Solutions announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHFS CHF Solutions
$0.37 /

+0.0068 (+1.90%)

CHFS CHF Solutions
$0.37 /

+0.0068 (+1.90%)

Recommendations
nVent Electric price target raised to $29 from $26 at Rosenblatt » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
NVT

nVent Electric

$19.62 /

+0.73 (+3.86%)

Rosenblatt analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/06/20 Barclays
nVent Electric upgraded to Overweight from Equal Weight at Barclays
12/10/19 CL King
nVent Electric initiated with a Neutral at CL King
NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

Recommendations
Xylem price target raised to $70 from $63 at Rosenblatt » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
XYL

Xylem

$70.03 /

+2.17 (+3.20%)

Rosenblatt analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XYL Xylem
$70.03 /

+2.17 (+3.20%)

XYL Xylem
$70.03 /

+2.17 (+3.20%)

05/15/20 Vertical Research
Xylem upgraded to Hold from Sell at Vertical Research
05/07/20 Cowen
Xylem price target lowered to $50 from $65 at Cowen
04/16/20 Vertical Research
Xylem downgraded to Sell from Hold at Vertical Research
04/08/20 Goldman Sachs
Xylem downgraded to Sell from Neutral at Goldman Sachs
XYL Xylem
$70.03 /

+2.17 (+3.20%)

Hot Stocks
Aldeyra reaches agreement with FDA to use RASP as treatment sign for DED » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
ALDX

Aldeyra

$4.65 /

-0.3 (-6.06%)

Aldeyra announced that,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

05/11/20 Oppenheimer
Aldeyra initiated with an Outperform at Oppenheimer
12/03/19 JonesTrading
Aldeyra dry eye data positive nearly across the board, says JonesTrading
10/22/19 Cantor Fitzgerald
Aldeyra assumed with an Overweight at Cantor Fitzgerald
10/14/19 Roth Capital
Ophthalmic therapies 'could go from 0 to 100 real quick,' says Roth Capital
ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

Hot Stocks
Potbelly reduces cash burn by 75%, says cash-neutral at store-level as of May 31 » 08:07
06/04/20
06/04
08:07
06/04/20
08:07
PBPB

Potbelly

$2.28 /

+0.05 (+2.24%)

Potbelly Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

12/11/19 Piper Jaffray
Potbelly downgraded to Neutral from Overweight at Piper Jaffray
PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

Recommendations
Elastic price target raised to $95 from $90 at Oppenheimer » 08:07
06/04/20
06/04
08:07
06/04/20
08:07
ESTC

Elastic

$89.23 /

+0.41 (+0.46%)

Oppenheimer analyst Ittai…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$89.23 /

+0.41 (+0.46%)

ESTC Elastic
$89.23 /

+0.41 (+0.46%)

06:26 Today Barclays
Elastic price target raised to $108 from $70 at Barclays
06:13 Today Piper Sandler
Elastic price target raised to $94 from $66 at Piper Sandler
05:04 Today Jefferies
Jefferies boosts Elastic target to $105, says buy on earnings pullback
06/01/20 RBC Capital
Elastic price target raised to $95 from $85 at RBC Capital
ESTC Elastic
$89.23 /

+0.41 (+0.46%)

ESTC Elastic
$89.23 /

+0.41 (+0.46%)

ESTC Elastic
$89.23 /

+0.41 (+0.46%)

Hot Stocks
DelMar Pharmaceuticals' VAL-083 selected for global GBM pivotal study » 08:07
06/04/20
06/04
08:07
06/04/20
08:07
DMPI

DelMar Pharmaceuticals

$0.81 /

-0.0069 (-0.85%)

DelMar Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DMPI DelMar Pharmaceuticals
$0.81 /

-0.0069 (-0.85%)

DMPI DelMar Pharmaceuticals
$0.81 /

-0.0069 (-0.85%)

09/06/19 Maxim
DelMar Pharmaceuticals initiated with a Buy at Maxim
DMPI DelMar Pharmaceuticals
$0.81 /

-0.0069 (-0.85%)

Recommendations
Roku weakness on new TCL TVs 'well overdone,' says Rosenblatt » 08:06
06/04/20
06/04
08:06
06/04/20
08:06
ROKU

Roku

$103.93 /

-6.895 (-6.22%)

Rosenblatt analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

06/03/20 Stephens
Roku may be seeing pressure from Best Buy TCL TVs, says Stephens
06/03/20 SunTrust
New TVs at Best Buy present 'modest' new competition for Roku, says Suntrust
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Stephens
Roku downgraded to Equal Weight on worries about TCL at Stephens
ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

Initiation
RNC Minerals initiated with a Buy at Stifel GMP » 08:05
06/04/20
06/04
08:05
06/04/20
08:05
RNKLF

RNC Minerals

$0.00 /

+ (+0.00%)

Stifel GMP analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Earnings
    Mohawk Group raises 2020 net revenue view $170M-$180M from $165M-$175M » 08:04
    06/04/20
    06/04
    08:04
    06/04/20
    08:04
    MWK

    Mohawk Group

    $4.78 /

    -0.04 (-0.83%)

    Consensus $168.48M. For…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    03/09/20 Roth Capital
    Mohawk Group resumed with a Buy at Roth Capital
    12/20/19
    Fly Intel: Top five analyst initiations
    12/20/19 DA Davidson
    Mohawk Group initiated with a Buy at DA Davidson
    07/11/19 National Securities
    Mohawk Group initiated with a Buy at National Securities
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    Upgrade
    Sally Beauty upgraded to Outperform at Oppenheimer » 08:04
    06/04/20
    06/04
    08:04
    06/04/20
    08:04
    SBH

    Sally Beauty

    $15.21 /

    +1.415 (+10.26%)

    As previously reported,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SBH Sally Beauty
    $15.21 /

    +1.415 (+10.26%)

    SBH Sally Beauty
    $15.21 /

    +1.415 (+10.26%)

    05:34 Today Oppenheimer
    Sally Beauty upgraded to Outperform from Perform at Oppenheimer
    04/27/20 DA Davidson
    Sally Beauty price target lowered to $10 from $14.50 at DA Davidson
    04/20/20 Raymond James
    Sally Beauty preliminary Q2 not as bad as feared, says Raymond James
    01/21/20 DA Davidson
    Sally Beauty upgraded to Neutral from Underperform at DA Davidson
    SBH Sally Beauty
    $15.21 /

    +1.415 (+10.26%)

    Hot Stocks
    Mohawk Group reports preliminary May net revenue increased approx. 105% » 08:03
    06/04/20
    06/04
    08:03
    06/04/20
    08:03
    MWK

    Mohawk Group

    $4.78 /

    -0.04 (-0.83%)

    Mohawk Group Holdings…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    03/09/20 Roth Capital
    Mohawk Group resumed with a Buy at Roth Capital
    12/20/19
    Fly Intel: Top five analyst initiations
    12/20/19 DA Davidson
    Mohawk Group initiated with a Buy at DA Davidson
    07/11/19 National Securities
    Mohawk Group initiated with a Buy at National Securities
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    Hot Stocks
    Mylan and Lupin granted marketing authorization for Nepexto in Europe » 08:03
    06/04/20
    06/04
    08:03
    06/04/20
    08:03
    MYL

    Mylan

    $17.54 /

    +0.08 (+0.46%)

    Mylan and Lupin announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    03/25/20 Cantor Fitzgerald
    Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
    02/06/20 BMO Capital
    Biogen price target raised to $317 from $297 at BMO Capital
    02/05/20 Baird
    Biogen price target raised to $290 from $250 at Baird
    02/05/20 Mizuho
    Biogen's Tecfidera win worth $15-$30 per share to DCF, Mizuho says
    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.